The coordinated buying by three major passive managers suggests growing institutional confidence in KURA, potentially signaling improved sentiment ahead of clinical data or regulatory catalysts. Traders should monitor for follow-on buying and any upcoming company announcements.
Executive Summary
Three major passive institutions — Morgan Stanley, Wells Fargo, and UBS — significantly increased their positions in Kura Oncology (KURA) during Q4 2024, collectively adding $5.0M in net new value. Despite one position showing a minor valuation decrease, the overall cluster reflects strong accumulation by large financial institutions.
Key Financial Metrics
Institutional Positions
Net institutional flow: $5.0M
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | DOUBLED | +171.3% | $28.5M | $4.9M |
| UBS | DOUBLED | +143% | $2.7M | $211.0K |
| Wells Fargo | ADD | +48.5% | $305.0K | -$155.6K |
Key Facts
- Morgan Stanley doubled its stake, adding 2.07M shares (171.3% increase), increasing value by $4.9M to $28.5M
- UBS doubled its position with a 143% share increase (185.7K shares added), boosting value by $211K to $2.7M
- Wells Fargo added 11.4K shares (48.5% increase), though the current value decreased slightly to $305K
- No institutional selling was detected in this quarter
Financial Impact
3 institutions accumulated $5.0M in net new positions during Q4 2024
Risk Factors
- All buyers are passive institutions, which may reflect index rebalancing rather than active conviction
- Wells Fargo's position decreased in value despite share increase, suggesting possible downward price pressure
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-KURA-2024-Q4 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 23d ago | 8-K | $12.09 $11.37 | ▼ −6.00% | ▼ −5.66% | — |
Sep 8, 2026 24d ago | 8-K | $12.52 $11.30 | ▼ −9.74% | ▼ −8.63% | — |
Aug 24, 2026 5w ago | Insider Cluster | $12.40 $12.65 | ▲ +2.02% | ▲ +1.55% | — |
Aug 21, 2026 6w ago | Insider Cluster | $11.89 $12.66 | ▲ +6.48% | ▲ +6.00% | — |
Aug 17, 2026 6w ago | Insider Buy | $12.33 $13.59 | ▲ +10.22% | ▲ +10.42% | — |
Aug 12, 2026 7w ago | Press Release | $10.09 $11.71 | ▲ +16.06% | ▲ +18.02% | — |
Aug 5, 2026 8w ago | Press Release | $9.20 $9.94 | ▲ +8.04% | ▲ +7.69% | — |
Jul 29, 2026 9w ago | 8-K | $9.31 $9.28 | ▼ −0.32% | ▼ −3.94% | — |
Jul 14, 2026 11w ago | Press Release | $11.24 $10.68 | ▼ −4.98% | ▼ −3.69% | — |
Jun 3, 2026 17w ago | Press Release | $8.66 $8.68 | ▲ +0.29% | ▲ +4.11% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access